Anagrelide hydrochloride and Insulin Glargine (U-100) Vials
Determining the interaction of Anagrelide hydrochloride and Insulin Glargine (U-100) Vials and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: anagrelide
Brand name: Agrylin
Synonyms: Anagrelide
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Anagrelide hydrochloride-Insulin Glargine (U-300) Pens
- Anagrelide hydrochloride-Insulin glargine and lixisenatide
- Anagrelide hydrochloride-Insulin glargine and lixisenatide Subcutaneous
- Anagrelide hydrochloride-Insulin glargine, recombinant Subcutaneous
- Anagrelide hydrochloride-Insulin glulisine
- Anagrelide hydrochloride-Insulin Glulisine (Cartridges and Pens)
- Insulin Glargine (U-100) Vials-Anakinra
- Insulin Glargine (U-100) Vials-Anakinra Subcutaneous
- Insulin Glargine (U-100) Vials-Analgesic Balm Greaseless
- Insulin Glargine (U-100) Vials-Analpram Advanced
- Insulin Glargine (U-100) Vials-Analpram E
- Insulin Glargine (U-100) Vials-Analpram E Cream